Log in
Enquire now
‌

US Patent 11266772 Use of heparin and carbohydrates to treat cancer

Patent 11266772 was granted and assigned to ExThera Medical on March, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
Current Assignee
ExThera Medical
ExThera Medical
Date Filed
December 9, 2014
Date of Patent
March 8, 2022
Patent Applicant
ExThera Medical
ExThera Medical
Patent Application Number
14565387
Patent Citations
‌
US Patent 10639413 Blood filtration system containing mannose coated substrate
‌
US Patent 10688239 Method for extracorporeal removal of a pathogenic microbe, an inflammatory cell or an inflammatory protein from blood
‌
US Patent 10857283 Wearable hemoperfusion device
‌
US Patent 10786615 Method for treating drug intoxication
‌
US Patent 10086126 Methods for removing cytokines from blood with surface immobilized polysaccharides
‌
US Patent 10188783 Method for extracorporeal removal of pathogenic microbe, an inflammatory cell or an inflammatory protein from blood
‌
US Patent 10457974 Methods for diagnosing infectious diseases using adsorption media
‌
US Patent 10487350 Methods for diagnosing infectious diseases using adsorption media
‌
US Patent 10537280 Device and method for removal of blood-borne pathogens, toxins and inflammatory cytokines
Patent Citations Received
‌
US Patent 12090261 Method for modulating endothelial glycocalyx structure
0
‌
US Patent 11911551 Method for treating drug intoxication
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11266772
Patent Primary Examiner
‌
Dale R Miller

Find more entities like US Patent 11266772 Use of heparin and carbohydrates to treat cancer

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.